HDFC Pharma And Healthcare Fund Regular - Growth
HDFC Pharma And Healthcare Fund Regular - Growth: Mutual Fund Overview
HDFC Pharma And Healthcare Fund Regular - Growth is an Sectoral-Pharma mutual fund with over 2.47 years of performance history. The scheme manages an AUM of ₹2030.8 Cr and has a NAV of ₹16.683. It is rated 'Not Rated' stars by analysts. Investors can begin a SIP with as little as ₹100.0, making it accessible for all types of investors. In the last 1 year, the fund has delivered a return of 6.69%.
Equity, Sectoral-Pharma, Principal at very high risk
1 Year Return 6.69% at 24 Mar 2026 03:20 PM
Fund Details
NAV 16.683
Sub-Type Sectoral-Pharma
Rating Not Rated
Min. SIP Amount ₹100.0
Fund Age(Year) 2.47
Fund Size(in Crores) 2030.8
Fund Performance
1 Month -2.02%
3 Month -1.35%
6 Month -3.7%
1 Year 6.69%
3 Year 0.0%
5 Year 0.0%
Know This Fund
As on 24 Mar 2026
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (98.22%) Market Cap Large Cap 26.97 Small Cap 30.45 Mid Cap 40.8 Top Sectors Healthcare 98.22 Top Holding Sun Pharmaceutical Industries 9.81 Thyrocare Technologies 1.39 Glenmark Pharmaceuticals 6.62 Krishna Institute 3.61 Divi's Laboratories 8.38 Ipca Laboratories 4.8 Wockhardt 1.73 Global Health 1.84 Laurus Labs 2.91 Acutaas Chemicals 3.6 Max Healthcare Institute 6.36 Shilpa Medicare 1.68 Rubicon Research 1.22 Bajaj Healthcare 0.92 Torrent Pharmaceuticals 2.34 Sai Life Sciences 2.09 Anthem Biosciences 4.46 Alkem Laboratories 6.21 Dr. Lal Pathlabs 1.63 Jubilant Pharmova 1.35 Lupin 6.44 Laxmi Dental 0.61 Aster DM Healthcare 5.42 Vijaya Diagnostic Centre 2.3 Fortis Healthcare 4.02 Gland Pharma 1.12 Eris Lifesciences 2.28 CORONA Remedies 0.55 Metropolis Healthcare 2.53
Debt & Others (1.78%) Sector Allocation Repo 1.88 Net Payables -0.1 Debt Credit Ratings Debt Category Others 1.78
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M -3.39% Ret 1Y 0.43% Ret 3Y 22.76% Ret 5Y 13.62%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M -3.39% Ret 1Y 0.43% Ret 3Y 22.76% Ret 5Y 13.62%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M -3.39% Ret 1Y 0.43% Ret 3Y 22.76% Ret 5Y 13.62%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M -5.37% Ret 1Y -2.07% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M -5.37% Ret 1Y -2.07% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M -5.37% Ret 1Y -2.07% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M -4.89% Ret 1Y -2.44% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M -5.4% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M -5.4% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M -5.4% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M -5.25% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 2.1%
Exit Load 1.0%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Dhruv Muchhal
Education Mr. Dhruv has done B.Com, CA and CFA
Experience Prior to joining HDFC MF,he has worked with Motilal Oswal Financial Services Ltd., Goldman Sachs, CRISIL Global Research & Analytics and Deloitte Haskins & Sells
Nikhil Mathur
Education Mr. Mathur has done B.Tech and PGDM in Finance
Experience Prior to joining HDFC Mutual Fund, he has worked with Ambit Capital, Goldman Sachs, Deloitte India and EY
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk
AMC and Fund details
Rank (total sets) 8
Date of Incorporation 2023-10-04
Total AUM 952319.77
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.
Take Your Next Step
HDFC Pharma And Healthcare Fund Regular - Growth FAQs
How to invest in HDFC Pharma And Healthcare Fund Regular - Growth?
Investing in HDFC Pharma And Healthcare Fund Regular - Growth through Motilal Oswal is simple and completely online. You just need to follow the step-by-step process below to get started in a few minutes.
- Log in to your Motilal Oswal account via the app or website
- Go to the Mutual Funds section
- Search for HDFC Pharma And Healthcare Fund Regular - Growth in the search bar
- Select your preferred investment mode – Lumpsum or SIP
- Enter investment details such as amount and linked bank account
- Complete your KYC, if not already done
- Review and confirm details including fund name, plan type, amount, and bank account
- Make the payment using Net Banking, UPI, or other available options
- Receive transaction confirmation via email or SMS
What is the expense ratio of HDFC Pharma And Healthcare Fund Regular - Growth?
The term expense ratio for HDFC Pharma And Healthcare Fund Regular - Growth or any other mutual fund is the annual fee charged by the fund house for managing your investment scheme. The expense ratio of HDFC Pharma And Healthcare Fund Regular - Growth is 2.1% as of 24 Mar 2026.
What is the NAV of HDFC Pharma And Healthcare Fund Regular - Growth?
The NAV of HDFC Pharma And Healthcare Fund Regular - Growth is ₹16.683 as of 24 Mar 2026.
What is the AUM of HDFC Pharma And Healthcare Fund Regular - Growth?
The AUM (Assets Under Management) of HDFC Pharma And Healthcare Fund Regular - Growth is the total value of assets managed by the fund at a given time, which is updated regularly. The AUM of HDFC Pharma And Healthcare Fund Regular - Growth is ₹2030.8 Cr as of 24 Mar 2026.
What is the PE and PB ratio of HDFC Pharma And Healthcare Fund Regular - Growth?
The PE ratio of HDFC Pharma And Healthcare Fund Regular - Growth shows how much investors are paying for the fund's underlying earnings, while the PB ratio indicates how the fund's holdings are valued compared to their book value.
Can I invest in SIP and Lump Sum in HDFC Pharma And Healthcare Fund Regular - Growth?
Yes, you can invest in HDFC Pharma And Healthcare Fund Regular - Growth through both SIP (Systematic Investment Plan) and lump sum options, depending on your investment preference and financial goals.
What is the return of HDFC Pharma And Healthcare Fund Regular - Growth in the last 5 years?
The return of HDFC Pharma And Healthcare Fund Regular - Growth in the last 5 years is 0.0%.
What is the minimum SIP investment required in HDFC Pharma And Healthcare Fund Regular - Growth?
The minimum SIP investment in HDFC Pharma And Healthcare Fund Regular - Growth depends on the fund's scheme rules and usually starts at a small amount. For HDFC Pharma And Healthcare Fund Regular - Growth, the minimum SIP amount is ₹100.0.
What is the current NAV of HDFC Pharma And Healthcare Fund Regular - Growth?
The NAV of HDFC Pharma And Healthcare Fund Regular - Growth, as of 24 Mar 2026, is ₹16.683.
Who manages the HDFC Pharma And Healthcare Fund Regular - Growth?
The fund managers responsible for HDFC Pharma And Healthcare Fund Regular - Growth are:
- Dhruv Muchhal
- Nikhil Mathur